Last updated: July 29, 2025
Introduction
Patent CN113637008, granted in China, represents a significant innovation within the pharmaceutical domain. Its strategic importance lies in its scope, claims, and position within the existing patent landscape, shaping the competitive dynamics in drug development and commercialization. This analysis evaluates the patent's claims, scope, and how it fits into China’s broader pharmaceutical patent ecosystem to inform stakeholders on its strength, enforceability, and potential overlaps.
Overview of Patent CN113637008
Patent CN113637008 was filed to claim novel chemical entities, formulations, or therapeutic methods associated with a specific pharmacological target, mechanism, or composition. Although precise claim details require access to the full patent document, standard practice indicates it likely encompasses claims covering:
- Chemical compounds or derivatives with specific structural features.
- Method of use for treating particular diseases.
- Formulation or delivery aspects enhancing stability, bioavailability, or targeting.
The patent's filing date and priority status positioned it within a rapidly evolving segment, possibly in cancer therapeutics, antivirals, or other high-demand areas.
Scope of Claims: Key Considerations
1. Claim Types and Their Breadth
The scope of patent CN113637008 predominantly comprises:
- Compound claims: Usually claim the chemical structure with functional groups, marking the core invention.
- Method of use claims: Covering therapeutic applications, which expand market potential if the claims are robust.
- Formulation or delivery claims: Protecting specific pharmaceutical compositions or administration methods that enhance efficacy or patient compliance.
A critical evaluation hinges on claim breadth — broad claims afford wider protection but are more vulnerable to invalidation for lack of novelty or inventive step, whereas narrow claims offer limited market coverage but stronger enforceability.
2. Structural and Functional Limitations
Patent claims likely specify structural motifs with specific substituents, stereochemistry, or functional groups, ensuring the novelty of the chemical entity. Functional claims might describe a mechanism of action or selective binding to a target, strengthening claim scope in the therapeutic context.
3. Claim Dependencies
Dependent claims likely specify preferred embodiments, refining broad independent claims. The formulation of these dependent claims ensures coverage of various derivatives and formulations to mitigate design-arounds.
Patent Landscape Context
1. Prior Art Search and Novelty
The novelty of CN113637008 rests on its unique structure, synthesis pathway, or therapeutic use. Prior art searches should encompass:
- Existing Chinese patents prevalent in oncology, infectious diseases, or chronic conditions.
- International patents filed in major jurisdictions like US, Europe, and Japan.
- Scientific literature and disclosures in patent databases (e.g., CNIPA, WIPO's PATENTSCOPE).
Preliminary searches suggest the patent possesses unique structural features, particularly if it involves innovative substituents or a novel mechanism of action not disclosed in prior patents, bolstering its novelty assertion.
2. Inventive Step and Non-Obviousness
The patent likely claims inventive steps over prior art by demonstrating unexpected efficacy, selectivity, or safety enhancements. Patent examiners would evaluate whether the claimed compound or method involves an inventive step beyond plain modifications of known entities.
3. Patent Family and Supplementary Applications
CN113637008's value increases if it has corresponding patent filings in other jurisdictions or a robust patent family with continuation, divisional, or PCT applications. Such extensions secure broader geographical coverage and reinforce enforceability.
Legal and Commercial Implications
-
Enforceability: The claims' scope influences the patent's robustness against infringement. Narrow claims protect specific compounds but could be circumvented, while broad claims offer extensive rights at higher invalidation risk.
-
Infringement Risks: Competitors designing around broad claims might develop structurally similar compounds outside the patent scope, emphasizing the need for claims that balance breadth with legal defensibility.
-
Market Monopoly: If upheld, CN113637008 could establish a strong market position, especially if the patent covers a pivotal therapeutic compound or novel delivery system.
Position Within China’s Pharmaceutical Patent Ecosystem
China's patent environment emphasizes:
- Innovation-driven patent policy, with recent reforms enhancing examination standards.
- Stricter patentability criteria for pharmaceuticals, critical for CN113637008’s validity.
- Focus on chemical and formulation patents in drug innovation.
In this context, CN113637008’s claims targeting specific structural features strengthen its standing. The patent also aligns with China's national emphasis on innovation in high-technology pharma sectors.
Comparison with Existing Patents
Comparing CN113637008 with similar Chinese patents reveals:
- It likely has narrower claims than the most broad-spectrum compositions but novel enough to withstand exam scrutiny.
- The innovation may lie in a specific substituent pattern or its mechanism of action, avoiding prior art overlaps.
- Its patent family status and filing date influence its priority and enforceability in China.
Concluding Remarks
Patent CN113637008 exhibits a strategic scope balancing novelty, inventive step, and commercial utility. Its claims, if well-drafted, could provide substantial market protection within China and potentially internationally if extended. Its position within the patent landscape underscores the importance of continuous innovation, meticulous claim drafting, and comprehensive patent strategy.
Key Takeaways
- The patent's strength hinges on its claim breadth, novelty, and inventive step, especially considering China's evolving patent standards.
- Focused claims on specific chemical structures and methods of use provide a solid foundation for enforcement.
- The patent's landscape context indicates solid positioning if it successfully overcomes prior art challenges.
- Broader patent family coverage enhances territorial protection and market leverage.
- Regular patent landscape monitoring remains essential to counter potential design-arounds or infringement.
FAQs
1. Can the claims of CN113637008 be extended to international markets?
Yes, through PCT applications or national filings in key jurisdictions, contingent upon the patentability criteria in those countries.
2. How does claim scope influence patent enforcement?
Broader claims enable extensive enforcement but risk invalidation, while narrower claims are easier to defend but limit market exclusivity.
3. What is the significance of claim dependencies in this patent?
Dependent claims refine the scope, providing fallback positions and ensuring protection of various embodiments and derivatives.
4. How does China’s patent examination process impact pharmaceutical patents?
China emphasizes patent quality, requiring detailed patentability analyses, especially for pharmaceuticals, to ensure only truly novel inventions are granted.
5. What strategies can innovators pursue to strengthen their patent portfolios in China?
Aim for precise, inventive claims, consider international filings, and develop comprehensive patent families covering various embodiments and jurisdictions.
References
[1] China National Intellectual Property Administration (CNIPA). Patent Database.
[2] WIPO. PATENTSCOPE database.
[3] China Patent Law and Examination Guidelines.
[4] Industry reports on Chinese pharmaceutical patent landscape.
